TG4010 is an active immunotherapy
designed to express the coding sequences of the MUC1 tumor-associated antigen and the cytokine, Interleukin-2 (IL2).
Listed on Alternext Paris since 2010, Neovacs is a biotechnology company focused on an active immunotherapy
technology platform (Kinoids) with applications in autoimmune and/or inflammatory diseases.
"Our company is focused on active immunotherapy
, which basically means stimulating the immune system to fight disease.
(12) Depending on the patient's response, a doubling of medication needed because of poor control may well be more costly than active immunotherapy
, especially as the injection frequency decreases.
Pharmexa, headquartered in Horsholm, Denmark, is a development stage company in the field of active immunotherapy
Open sessions will focus on today's hottest oncology issues along with updated information on new drugs, evidence-based practice, patient teaching, secondary cancers, acute leukemia, hereditary cancers, genetics, active immunotherapy
, multisite research, symptom management, pain management, end-of-life care, targeted and biologic therapies, healthcare advocacy, and nurturing caregivers.
Genitope Corporation's lead product candidate, MyVax personalized immunotherapy, is a patient-specific active immunotherapy
based on the unique genetic makeup of a patient's tumor and is designed to activate the patient's immune system to identify and attack cancer cells.
, sometimes called a cancer vaccine, has shown considerable promise in treating non-Hodgkin's lymphoma," said Dan W.
(The CAS found no differences in asthma symptoms between the active immunotherapy
and placebo groups.)
In the best of situations, I would expect only 25%-30% of people in this older age group with Alzheimer's would be likely to mount sufficient antibody response to remove plaques with active immunotherapy
," he said.
"This novel peptide is significant because it could provide the basis for an active immunotherapy
that uses T-cells to attack and destroy cancer cells that overexpress the HER-2 antigen," stated Gail Maderis, president of Genzyme Molecular Oncology.